Your browser doesn't support javascript.
loading
Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial.
Clegg, Lindsay E; Penland, Robert C; Bachina, Srinivas; Boulton, David W; Thuresson, Marcus; Heerspink, Hiddo J L; Gustavson, Stephanie; Sjöström, C David; Ruggles, James A; Hernandez, Adrian F; Buse, John B; Mentz, Robert J; Holman, Rury R.
Afiliação
  • Clegg LE; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, 1 MedImmune Way, Gaithersburg, MD, 20878, USA. lindsay.clegg1@astrazeneca.com.
  • Penland RC; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Boston, USA.
  • Bachina S; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Boston, USA.
  • Boulton DW; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, 1 MedImmune Way, Gaithersburg, MD, 20878, USA.
  • Thuresson M; Statisticon AB, Uppsala, Sweden.
  • Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Gustavson S; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Sjöström CD; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ruggles JA; BioPharmaceuticals, AstraZeneca, Wilmington, DE, USA.
  • Hernandez AF; Duke University and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
  • Buse JB; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Mentz RJ; Duke University and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
  • Holman RR; Diabetes Trials Unit, University of Oxford, Oxford, UK.
Cardiovasc Diabetol ; 18(1): 138, 2019 10 22.
Article em En | MEDLINE | ID: mdl-31640705
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Inibidores do Transportador 2 de Sódio-Glicose / Exenatida / Taxa de Filtração Glomerular / Rim Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Inibidores do Transportador 2 de Sódio-Glicose / Exenatida / Taxa de Filtração Glomerular / Rim Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article